Picture of Abacus Global Management logo

ABX Abacus Global Management News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsAdventurousMid CapSuper Stock

Abacus Life Inc reports results for the quarter ended in September 30 - Earnings Summary

* Abacus Life Inc  ABL.OQ  reported quarterly adjusted
earnings of
20 cents​​ per share for the quarter ended September 30.  The
mean expectation of four analysts for the quarter was
for earnings of 14 cents per share. Wall Street expected
results to range from 12 cents to 14 cents per share.
    * Revenue was $28.15 million​; analysts expected $28.46
million. 
    * Abacus Life Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * The company reported a quarterly loss of $5.13 million.
    * Abacus Life Inc shares had fallen by 12.9% this
quarter and
lost 8.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 5.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the multiline
insurance
& brokers peer group is also "buy"

Wall Street's median 12-month price target for Abacus Life Inc
is 13.75 
This summary was machine generated from LSEG data November 8 at
05:28 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.14           0.20           Beat
 Jun. 30 2024      0.13           0.18           Beat
                                  0.11

Recent news on Abacus Global Management

See all news